These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 37903944)

  • 41. Interactions between active pharmaceutical ingredients and excipients affecting bioavailability: impact on bioequivalence.
    García-Arieta A
    Eur J Pharm Sci; 2014 Dec; 65():89-97. PubMed ID: 25236823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Effects of Pharmaceutical Excipients on Gastrointestinal Tract Metabolic Enzymes and Transporters-an Update.
    Zhang W; Li Y; Zou P; Wu M; Zhang Z; Zhang T
    AAPS J; 2016 Jul; 18(4):830-43. PubMed ID: 27184579
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potentially harmful excipients in neonatal medications: a multicenter nationwide observational study in Japan.
    Saito J; Nadatani N; Setoguchi M; Nakao M; Kimura H; Sameshima M; Kobayashi K; Matsumoto H; Yoshikawa N; Yokoyama T; Takahashi H; Suenaga M; Watanabe R; Imai K; Obara M; Hashimoto M; Yamamoto K; Fujiwara N; Sakata W; Nagai H; Enokihara T; Katayama S; Takahashi Y; Araki M; Iino K; Akiyama N; Katsu H; Fushimi K; Takeda T; Torimoto M; Kishi R; Mitsuya N; Kihara R; Hasegawa Y; Hamada Y; Kimura T; Wada M; Tanzawa A; Yamatani A
    J Pharm Health Care Sci; 2021 Jul; 7(1):23. PubMed ID: 34193299
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new approach to the safety assessment of pharmaceutical excipients. The Safety Committee of the International Pharmaceutical Excipients Council.
    Steinberg M; Borzelleca JF; Enters EK; Kinoshita FK; Loper A; Mitchell DB; Tamulinas CB; Weiner ML
    Regul Toxicol Pharmacol; 1996 Oct; 24(2 Pt 1):149-54. PubMed ID: 8933628
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extemporaneous compounding in veterinary practice: a New Zealand perspective.
    Gargiulo DA; Chemal C; Joda L; Lee YJ; Pilkington M; Haywood A; Garg S
    N Z Vet J; 2013 Nov; 61(6):311-5. PubMed ID: 23544952
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Promoting veterinary medication safety - Exploring the competencies of community pharmacy professionals in veterinary pharmacotherapy.
    Immonen H; Raekallio MR; Holmström AR
    Vet Anim Sci; 2023 Sep; 21():100310. PubMed ID: 37664413
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of hydroperoxides in common pharmaceutical excipients.
    Wasylaschuk WR; Harmon PA; Wagner G; Harman AB; Templeton AC; Xu H; Reed RA
    J Pharm Sci; 2007 Jan; 96(1):106-16. PubMed ID: 16917844
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insights into Current Veterinary Pharmaceutics for Companion Animals in Japan: A Study Based on Data from the Veterinary Drug Side Effect Database.
    Konno T; Suzuki H; Nakamura H; Murai Y
    Biol Pharm Bull; 2022 Sep; 45(9):1225-1231. PubMed ID: 35768216
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Are Excipients Inert? Phenytoin Pharmaceutical Investigations with New Incompatibility Insights.
    Amaral Silva D; Löbenberg R; Davies NM
    J Pharm Pharm Sci; 2018; 21(1s):29745. PubMed ID: 29702046
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Applications of various analytical techniques in quality control of pharmaceutical excipients.
    Kumar M; Bhatia R; Rawal RK
    J Pharm Biomed Anal; 2018 Aug; 157():122-136. PubMed ID: 29787965
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Excipient variability and its impact on dosage form functionality.
    Dave VS; Saoji SD; Raut NA; Haware RV
    J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bridging the Gap: A Comparative Investigation of Pharmaceutical Excipient Regulations.
    Mali A; Kuvar V; Bharadwaj S
    Ther Innov Regul Sci; 2024 Mar; 58(2):258-272. PubMed ID: 38055157
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact Of Excipient Variability On Drug Product Processing And Performance.
    Peng Soh JL; Liew CV; Sia Heng PW
    Curr Pharm Des; 2015; 21(40):5890-9. PubMed ID: 26446469
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Final report on the safety assessment of Ricinus Communis (Castor) Seed Oil, Hydrogenated Castor Oil, Glyceryl Ricinoleate, Glyceryl Ricinoleate SE, Ricinoleic Acid, Potassium Ricinoleate, Sodium Ricinoleate, Zinc Ricinoleate, Cetyl Ricinoleate, Ethyl Ricinoleate, Glycol Ricinoleate, Isopropyl Ricinoleate, Methyl Ricinoleate, and Octyldodecyl Ricinoleate.
    Int J Toxicol; 2007; 26 Suppl 3():31-77. PubMed ID: 18080873
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generation of formaldehyde by pharmaceutical excipients and its absorption by meglumine.
    Fujita M; Ueda T; Handa T
    Chem Pharm Bull (Tokyo); 2009 Oct; 57(10):1096-9. PubMed ID: 19801864
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Possible effects of excipients used in the parenteral drugs administered in critically ill adults, children, and neonates.
    Sridharan K; Hasan HM; Al Jufairi M; Al Daylami A; Al Ansari E; Qader AM; Pasha SAA
    Expert Opin Drug Saf; 2020 Dec; 19(12):1625-1640. PubMed ID: 32767900
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety of "inert" additives or excipients in paediatric medicines.
    Nahata MC
    Arch Dis Child Fetal Neonatal Ed; 2009 Nov; 94(6):F392-3. PubMed ID: 19846397
    [No Abstract]   [Full Text] [Related]  

  • 59. Gamma sterilization of pharmaceuticals--a review of the irradiation of excipients, active pharmaceutical ingredients, and final drug product formulations.
    Hasanain F; Guenther K; Mullett WM; Craven E
    PDA J Pharm Sci Technol; 2014; 68(2):113-37. PubMed ID: 24668600
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.